В России, как и в большинстве индус

В России, как и в большинстве индустриальных стран, сердечно-сосудистые заболевания (ССЗ) занимают первое место в структуре инвалидизации и смертности.
Несмотря на существенные достижения в области медицины и биологии, заболеваемость и смертность от атеросклеротических заболеваний остаются на недопустимо высоком уровне, в то время как арсенал эффективных терапевтических средств и адекватных целей антиатеросклеротической терапии остается весьма ограниченным. Современные алгоритмы оценки сердечно-сосудистого риска, учитывающие совокупное взаимодействие нескольких факторов риска, в состоянии объяснить около 70% вариабельности возникновения острого инфаркта миокарда [1].

Результаты (английский) 1:

In Russia, as in most industrialized countries, cardiovascular disease (CVD) took first place in the structure of disability and mortality. Despite the significant achievements in the field of medicine and biology, morbidity and mortality from atherosclerotic diseases remain at an unacceptably high level, while the arsenal of effective Therapeutics and appropriate purposes antiaterosklerotičeskoj therapy remains very limited. Modern algorithms for assessing cardiovascular risk, taking into account the combined interaction of several risk factors, able to explain about 70% of the variability of the occurrence of acute myocardial infarction [1].

Результаты (английский) 2:

In Russia, as in most industrialized countries, cardiovascular disease (CVD) took first place in the structure of morbidity and mortality.
Despite significant advances in medicine and biology, morbidity and mortality from atherosclerotic disease remain unacceptably high in the While the arsenal of effective therapeutics and adequate purposes antiatherosclerotic therapy remains very limited. Modern algorithms for the evaluation of cardiovascular risk, taking into account the combined interaction of several risk factors explain about 70% of the variability of acute myocardial infarction [1].

Результаты (английский) 3:

in russia, as in most industrialized countries, cardiovascular diseases (cvd) took the first place in the structure of disability and mortality.
despite significant achievements in the field of medicine and biology, morbidity and mortality from атеросклеротических diseases remain unacceptably high.while arsenal of effective therapeutic means and appropriate goals антиатеросклеротической therapy remains very limited. modern algorithms of evaluating cardio vascular risk.taking account of the interaction of multiple risk factors, able to explain about 70% of вариабельности acute myocardial infarction [1].